Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Paula Tudoran

THE TRUTH ABOUT: Psychedelics without the trip heavyweights like neuralink coinbase twitch back ai startup developing least psychedelic psychedelic drug - The Untold Story

Wolfers, Smith Warn Trump's Tariffs Could Hit US Patients And Last

Mindstate Design Labs is developing drugs that aim to deliver psychedelic benefits without a trip, drawing funding from Y Combinator and the founders of OpenAI, Neuralink, Instacart (NASDAQ:CART), Coinbase (NASDAQ:COIN), and Twitch, according to Wired.

The company built Osmanthus, an AI platform that links biochemical profiles of psychoactive compounds to more than 70,000 human trip reports from sources that include clinical datasets, forums, social media, Reddit (NYSE:RDDT), and the dark web, Wired reported.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.